Extendicare Inc. (TSE:EXE - Free Report) - Research analysts at Cormark issued their FY2024 earnings estimates for Extendicare in a research note issued to investors on Wednesday, February 19th. Cormark analyst K. Mcphee forecasts that the company will post earnings per share of $0.79 for the year. Cormark has a "Moderate Buy" rating on the stock. The consensus estimate for Extendicare's current full-year earnings is $0.61 per share. Cormark also issued estimates for Extendicare's FY2025 earnings at $0.74 EPS, FY2026 earnings at $0.87 EPS and FY2027 earnings at $0.95 EPS.
Several other equities research analysts have also recently weighed in on EXE. BMO Capital Markets set a C$11.00 price target on shares of Extendicare and gave the company a "market perform" rating in a research report on Thursday, January 30th. TD Securities boosted their target price on shares of Extendicare from C$9.50 to C$10.50 and gave the company a "hold" rating in a report on Thursday, November 14th. Finally, Royal Bank of Canada lifted their price target on Extendicare from C$9.50 to C$11.00 and gave the stock a "sector perform" rating in a research report on Thursday, November 28th. Three investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of C$10.25.
View Our Latest Research Report on EXE
Extendicare Stock Performance
Extendicare stock opened at C$11.53 on Friday. The stock has a market cap of C$962.37 million, a P/E ratio of 14.70 and a beta of 1.26. The firm's fifty day moving average price is C$10.50 and its 200-day moving average price is C$9.59. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62. Extendicare has a fifty-two week low of C$6.63 and a fifty-two week high of C$11.71.
Extendicare Announces Dividend
The company also recently disclosed a monthly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 17th will be issued a $0.04 dividend. The ex-dividend date is Friday, February 28th. This represents a $0.48 annualized dividend and a dividend yield of 4.16%. Extendicare's payout ratio is currently 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
